NCT05356312Available不适用
Retrospective Analysis of Glioblastoma Patients With Immune Therapies
Zentrum fur Humangenetik Tuebingen1 个研究点 分布在 1 个国家开始时间: 2022年5月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- Available
- 发起方
- 试验地点
- 1
研究概览
简要总结
The treatment of patients with World Health Organization (WHO) grade 4 malignant glioma has not seen any significant breakthrough the past years. Following surgery and radio / chemotherapy patients still experience a very high recurrence risk and the prognosis is dismal. The investigators observed patients with grade IV malignant glioma receiving individualized treatment based on their molecular profile including fully personalized vaccines.
研究设计
- 研究类型
- Expanded Access
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •malignant glioma, IDH WT
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Investigation of the efficacy of lapatinib plus temozolomide combination, in recurrent brain tumors. A phase I/II study.patients with recurrent or refractory gliomasCancer - BrainACTRN12611000418976Hellenic Cooperative Oncology Group66
进行中（未招募）
1 期
Study to evaluate the potentiation effect of radiotherapy by AGuIX nanoparticles for the treatment of persistent glioblastomaPersistent Glioblastoma Multiforme, grade IVMedDRA version: 20.0Level: PTClassification code 10018337Term: Glioblastoma multiformeSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-003774-32-ITDIPARTIMENTO BIOMEDICINA E PREVENZIONE UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA30
撤回
2 期
Bevacizumab With or Without Surgery for Adult GlioblastomasBrain NeoplasmGlioblastomaNCT01413438National Institute of Neurological Disorders and Stroke (NINDS)
招募中
3 期
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III StudyFirst Progression of GlioblastomaNCT05904119European Organisation for Research and Treatment of Cancer - EORTC411
招募中
2 期
Surgery for Recurrent GlioblastomaGlioblastomaNCT02394626Insel Gruppe AG, University Hospital Bern120